Figure S1 from Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations

Paul Yenerall,Rahul K. Kollipara,Kimberley Avila,Michael Peyton, Christopher A. Eide,Daniel Bottomly,Shannon K. McWeeney,Yan Liu,Kenneth D. Westover,Brian J. Druker,John D. Minna,Ralf Kittler

crossref（2023）

引用 0|浏览1

暂无评分

摘要

Expression of RUVBL1 variants identified by LentiMutate confer resistance to compound B Individual cDNAs were expressed in the H1993 (left) or H2009 (right) cell lines under a doxycycline-inducible promoter. Values shown are averages of two biological replicates {plus minus} the standard deviation.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要